PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Diagnostic laboratories - Market size and forecast 2018-2023 • Hospitals - Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Growing adoption of POC testing products • Growing access to fourth-generation testing products • Decreasing prices of HIV tests PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott Laboratories • Becton Dickinson and Co. • bioMérieux SA • Bio-Rad Laboratories Inc. • Danaher Corp. • F. Hoffmann-La Roche Ltd. • OraSure Technologies Inc. • PerkinElmer Inc. • QIAGEN NV • Siemens Healthineers AG PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: End-user - Market share 2018-2023 (%) Exhibit 19: Comparison by end-user Exhibit 20: Diagnostic laboratories - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Diagnostic laboratories - Year-over-year growth 2019-2023 (%) Exhibit 22: Hospitals - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Hospitals - Year-over-year growth 2019-2023 (%) Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Others - Year-over-year growth 2019-2023 (%) Exhibit 26: Market opportunity by end-user Exhibit 27: Customer landscape Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 31: North America - Year-over-year growth 2019-2023 (%) Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 35: Asia - Year-over-year growth 2019-2023 (%) Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 37: ROW - Year-over-year growth 2019-2023 (%) Exhibit 38: Key leading countries Exhibit 39: Market opportunity Exhibit 40: Impact of drivers and challenges Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Abbott Laboratories - Vendor overview Exhibit 47: Abbott Laboratories - Business segments Exhibit 48: Abbott Laboratories - Organizational developments Exhibit 49: Abbott Laboratories - Geographic focus Exhibit 50: Abbott Laboratories - Segment focus Exhibit 51: Abbott Laboratories - Key offerings Exhibit 52: Becton Dickinson and Co. - Vendor overview Exhibit 53: Becton Dickinson and Co. - Business segments Exhibit 54: Becton Dickinson and Co. - Organizational developments Exhibit 55: Becton Dickinson and Co. - Geographic focus Exhibit 56: Becton Dickinson and Co. - Segment focus Exhibit 57: Becton Dickinson and Co. - Key offerings Exhibit 58: bioMérieux SA - Vendor overview Exhibit 59: bioMérieux SA - Business segments Exhibit 60: bioMérieux SA - Organizational developments Exhibit 61: bioMérieux SA - Geographic focus Exhibit 62: bioMérieux SA - Key offerings Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 64: Bio-Rad Laboratories Inc. - Business segments Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings Exhibit 69: Danaher Corp. - Vendor overview Exhibit 70: Danaher Corp. - Business segments Exhibit 71: Danaher Corp. - Organizational developments Exhibit 72: Danaher Corp. - Geographic focus Exhibit 73: Danaher Corp. - Segment focus Exhibit 74: Danaher Corp. - Key offerings Exhibit 75: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 76: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 77: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 78: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 79: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 80: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 81: OraSure Technologies Inc. - Vendor overview Exhibit 82: OraSure Technologies Inc. - Business segments Exhibit 83: OraSure Technologies Inc. - Organizational developments Exhibit 84: OraSure Technologies Inc. - Geographic focus Exhibit 85: OraSure Technologies Inc. - Segment focus Exhibit 86: OraSure Technologies Inc. - Key offerings Exhibit 87: PerkinElmer Inc. - Vendor overview Exhibit 88: PerkinElmer Inc. - Business segments Exhibit 89: PerkinElmer Inc. - Organizational developments Exhibit 90: PerkinElmer Inc. - Geographic focus Exhibit 91: PerkinElmer Inc. - Segment focus Exhibit 92: PerkinElmer Inc. - Key offerings Exhibit 93: QIAGEN NV - Vendor overview Exhibit 94: QIAGEN NV - Product segments Exhibit 95: QIAGEN NV - Organizational developments Exhibit 96: QIAGEN NV - Geographic focus Exhibit 97: QIAGEN NV - Segment focus Exhibit 98: QIAGEN NV - Key offerings Exhibit 99: Siemens Healthineers AG - Vendor overview Exhibit 100: Siemens Healthineers AG - Business segments Exhibit 101: Siemens Healthineers AG - Organizational developments Exhibit 102: Siemens Healthineers AG - Geographic focus Exhibit 103: Siemens Healthineers AG - Segment focus Exhibit 104: Siemens Healthineers AG - Key offerings Exhibit 105: Validation techniques employed for market sizing Exhibit 106: Definition of market positioning of vendors  

Abbott Laboratories, Becton Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, and Siemens Healthineers AG.